Nevertheless, further studies are needed to elucidate the function of ADAM17 in mediating PARPi resistance mechanisms in ovarian cancer therapy, in order to identify suitable therapy formats including combinatorial treatments to overcome PARPi resistance in this devastating disease. The gene discussed is ADAM17; the disease is ovarian carcinoma.